Therapeutic potential for KCC2-targeted neurological diseases()

Patients with neurological diseases, such as schizophrenia, tend to show low K(+)-Cl(-) co-transporter 2 (KCC2) levels in the brain. The cause of these diseases has been associated with stress and neuroinflammation. However, since the pathogenesis of these diseases is not yet fully investigated, dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Kazuo, Kuwahara, Yoshikazu, Igarashi, Kento, Kitanaka, Junichi, Kitanaka, Nobue, Takashi, Yuko, Tanaka, Koh-ichi, Roudkenar, Mehryar Habibi, Roushandeh, Amaneh Mohammadi, Kurimasa, Akihiro, Nishitani, Yoshihiro, Sato, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665825/
https://www.ncbi.nlm.nih.gov/pubmed/38022385
http://dx.doi.org/10.1016/j.jdsr.2023.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665825/
https://www.ncbi.nlm.nih.gov/pubmed/38022385
http://dx.doi.org/10.1016/j.jdsr.2023.11.001

Ejemplares similares